BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 983116)

  • 1. Activity of liver microsomal mono-oxygenases on some epoxide-forming cyclic tricyclic drugs. I. Kinetics in vitro.
    Pachecka J; Salmona M; Cantoni L; Mussini E; Pantarotto C; Frigerio A; Belvedere G
    Xenobiotica; 1976 Oct; 6(10):593-8. PubMed ID: 983116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsomal styrene mono-oxygenase and styrene epoxide hydrase activities in rats.
    Salmona M; Pachecka J; Cantoni L; Belvedere G; Mussini E; Garattini S
    Xenobiotica; 1976 Oct; 6(10):585-91. PubMed ID: 10684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of stable epoxides in the metabolism of tricyclic drugs.
    Frigerio A; Cavo-Briones M; Belvedere G
    Drug Metab Rev; 1976; 5(2):197-218. PubMed ID: 802468
    [No Abstract]   [Full Text] [Related]  

  • 4. Stereoselective formations of K-region and non-K-region epoxides in the metabolism of chrysene by rat liver microsomal cytochrome P-450 isozymes.
    Yang SK; Bao ZP
    Mol Pharmacol; 1987 Jul; 32(1):73-80. PubMed ID: 3037304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic hydration of butadiene monoxide and its importance in the metabolism of butadiene.
    Malvoisin E; Mercier M; Roberfroid M
    Adv Exp Med Biol; 1981; 136 Pt A():437-44. PubMed ID: 7344474
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of carbamazepine and its epoxide metabolite in human and rat liver in vitro.
    Tybring G; von Bahr C; Bertilsson L; Collste H; Glaumann H; Solbrand M
    Drug Metab Dispos; 1981; 9(6):561-4. PubMed ID: 6120817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of chrysene and phenanthrene to bay-region diol epoxides by rat liver enzymes.
    Nordqvist M; Thakker DR; Vyas KP; Yagi H; Levin W; Ryan DE; Thomas PE; Conney AH; Jerina DM
    Mol Pharmacol; 1981 Jan; 19(1):168-78. PubMed ID: 7207460
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings:Formation of stable epoxides in the metabolism of tricyclic drugs.
    Frigerio A
    Ital J Biochem; 1976; 25(2):184-6. PubMed ID: 950293
    [No Abstract]   [Full Text] [Related]  

  • 9. Epoxides as stable detoxification products of some tricyclic drugs.
    Frigerio A; Belvedere G; Pantarotto C
    Boll Chim Farm; 1975 Aug; 114(8):421-3. PubMed ID: 1182060
    [No Abstract]   [Full Text] [Related]  

  • 10. Accumulation of an epoxy intermediate during the hepatic microsomal metabolism of cis-stilbene to threo-stilbene glycol due to the inhibition of epoxide hydrolase by trans-stilbenimine.
    Watabe T; Akamatsu K
    Biochem Pharmacol; 1974 Jul; 23(13):1845-51. PubMed ID: 4458667
    [No Abstract]   [Full Text] [Related]  

  • 11. The type I binding of some aliphatic epoxides to cytochrome P-450 and their inhibition of mono-oxygenase activity.
    Serrentino R; Citti L; Gervasi PG; Turchi G
    Ital J Biochem; 1983; 32(2):111-23. PubMed ID: 6629728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin K epoxide reductase activity in the metabolism of epoxides.
    Liptay-Reuter I; Dose K; Guenthner T; Wörner W; Oesch F
    Biochem Pharmacol; 1985 Aug; 34(15):2617-20. PubMed ID: 4015704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biphasic kinetic profile for carbamazepine epoxide formation.
    van Boxtel CJ; Rane A; Wilson JT
    Res Commun Chem Pathol Pharmacol; 1977 Nov; 18(3):573-6. PubMed ID: 928955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The perinatal development of epoxide-metabolizing enzyme activities in liver and extrahepatic organs of guinea pig and rabbit.
    James MO; Foureman GL; Law FC; Bend JR
    Drug Metab Dispos; 1977; 5(1):19-28. PubMed ID: 13972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of carbamazepine-10,11- epoxide before and after autoinduction in rhesus monkeys.
    Patel IH; Levy RH; Trager WF
    J Pharmacol Exp Ther; 1978 Sep; 206(3):607-13. PubMed ID: 100595
    [No Abstract]   [Full Text] [Related]  

  • 16. 3-Hydroxyacetaminophen: a microsomal metabolite of acetaminophen. Evidence against an epoxide as the reactive metabolite of acetaminophen.
    Hinson JA; Pohl LR; Monks TJ; Gillette JR; Guengerich FP
    Drug Metab Dispos; 1980; 8(5):289-94. PubMed ID: 6107223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fate of epoxides.
    Oesch F
    Adv Exp Med Biol; 1981; 136 Pt A():39-52. PubMed ID: 7046377
    [No Abstract]   [Full Text] [Related]  

  • 18. Distinct rat hepatic microsomal epoxide hydrolases catalyze the hydration of cholesterol 5,6 alpha-oxide and certain xenobiotic alkene and arene oxides.
    Levin W; Michaud DP; Thomas PE; Jerina DM
    Arch Biochem Biophys; 1983 Feb; 220(2):485-94. PubMed ID: 6401984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hydration of sterically hindered epoxides by epoxide hydrolase of the rat and rabbit.
    Walker CH; Timms CW; Wolf CR; Oesch F
    Biochem Pharmacol; 1986 Feb; 35(3):499-503. PubMed ID: 3947384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: in vitro/in vivo correlation.
    Kerr BM; Rettie AE; Eddy AC; Loiseau P; Guyot M; Wilensky AJ; Levy RH
    Clin Pharmacol Ther; 1989 Jul; 46(1):82-93. PubMed ID: 2501059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.